Recent Updates
Recently added Catalysts
BFLY Positive Sentiment

Butterfly Network to Participate at the 8th Annual Evercore Healthcare Conference

Key Takeaway: Butterfly Network, Inc. will participate in the 8th Annual Evercore Healthcare Conference, with CEO Joseph DeVivo and CFO Megan Carlson leading a fireside chat and one-on-one investor meetings. The event is scheduled for December 2, 2025, in Coral Gables, FL. A live webcast will be available for those unable to attend in person.
Price reaction · baseline $2.32 (2025-11-20 close) · hit pre-market · clean, no other BFLY news in the window
day 0 close
+14.2%
day 1 · peak
+41.4%
day 3
+32.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Butterfly Network is participating in a prominent healthcare conference.
  • The company has received prestigious awards for its medical technology.
  • Butterfly's innovations are recognized for improving healthcare accessibility.

Full Press Release Details

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that Joseph DeVivo, President, Chief Executive Officer & Chairman and Megan Carlson, Senior Vice President & Interim Chief Financial Officer will participate in a fireside chat and host one-on-one investor meetings at the 8th Annual Evercore Healthcare Conference. The fireside chat will take place on Tuesday, December 2, 2025, at 1:20 pm ET in Coral Gables, FL.
A live webcast of the fireside chat will be available in theEvents & Presentationssection of the Butterfly investor website, and available for replay following the event.
To schedule a one-on-one meeting with Mr. DeVivo and Ms. Carlson, please reach out to your Evercore representative.
About Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company driving a digital revolution in medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. In 2018, Butterfly launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ. The iQ+ followed in 2020, and the iQ3 in 2024, each with improved processing power and performance by leveraging Moore’s Law. The iQ3 earned Best Medical Technology at the 2024 Prix Galien USA Awards, a prestigious honor and one of the highest accolades in healthcare. Butterfly’s innovations have also been recognized by Fierce 50, TIME’s Best Inventions and Fast Company’s World Changing Ideas, among other achievements.
Butterfly combines advanced hardware, intelligent software, AI, services, and education to drive adoption of affordable, accessible imaging. Clinical publications demonstrate that its handheld ultrasound probes paired with Compass™ enterprise workflow software, can help hospital systems improve care workflows, reduce costs, and enhance provider economics. With a cloud-based solution that enables care anywhere through next-generation mobility, Butterfly aims to democratize healthcare by addressing critical global healthcare challenges. Butterfly devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, Australia, Europe, the Middle East, North America and South America; to learn more about Butterfly’s Global Health Program, please visit:https://www.butterflynetwork.com/global-health.

Frequently Asked Questions

When is Butterfly Network's participation in the conference?

Butterfly Network will participate in the conference on December 2, 2025.

Who will represent Butterfly Network at the conference?

Joseph DeVivo and Megan Carlson will represent Butterfly Network.

Where will the conference take place?

The conference will be held in Coral Gables, Florida.

Will there be a webcast of the event?

Yes, a live webcast of the fireside chat will be available.

Last updated: Nov 21, 2025